About Ignota Labs
Ignota Labs is a Healthcare company based in London (United Kingdom) founded in 2021 by Layla Hosseini-Gerami and Sam Windsor. AI-driven toxicity prediction tools for early-stage drug discovery scientists. Ignota Labs has raised $6.9 million across 1 funding round from investors including Montage Ventures, AIX Ventures and Modi Ventures. The company has 6 employees. Its chief executive, as recorded, is Sam Windsor. Ignota Labs offers products and services including SAFEPATH. Its focus areas include Services for Healthcare Providers, BPO, Outsourced Clinical Services and Drug Compounding. Its legal entity is ABSOLUTEAI LTD.
Company details
Ignota Labs is a technology startup in the pharmaceutical sector that provides AI-driven toxicity prediction tools for early-stage drug discovery scientists. Their suite of tools, TOXSCAPE, helps scientists identify and understand safety issues during the drug discovery process, reducing expensive setbacks and delays.
- Headquarters London, United Kingdom
- Employees 6
- Founders Layla Hosseini-Gerami, Sam Windsor
- SectorsHealthcare
- Email••••••••
- Website ignotalabs.ai
- Social LinkedIn
- Legal Name Absoluteai Ltd
- Date of Incorporation 14 Oct, 2021
- Jurisdiction LONDON, ENGLAND
- Total Equity Funding$6.9M (USD)
in 1 rounds
- Latest Funding Round$6.9M (USD), Seed
Feb 2025
- InvestorsMontage Ventures
& 4 more
- Employee Count6
Products & Services of Ignota Labs
Ignota Labs offers a comprehensive portfolio of products and services, including SAFEPATH.
AI model identifies and mitigates drug safety issues in trials.
Funding Insights of Ignota Labs
Ignota Labs has successfully raised a total of $6.9M through 1 strategic funding round. The most recent funding activity was a Seed round of $6.9 million completed in February 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $6.9M
- Total Rounds 1
- Last Round Seed — $6.9M
- First Round $6.9M
(Feb 2025)
- Investors Count 5
All 1 funding rounds of Ignota Labs with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2025 | $6.9M | Seed | – | Montage Ventures, AIX Ventures |
5 investors in total: 5 institutional.
Investors in Ignota Labs
Ignota Labs has secured backing from 5 investors, including venture fund investors. Prominent investors backing the company include Montage Ventures, AIX Ventures and Modi Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
US focused growth stage VC firm | montageventures.com | Menlo Park, United States | ||
Venture capital is provided to AI-powered companies by AIX Ventures. | aixventures.com | Palo Alto, United States | ||
Modi Ventures is focused on investments in tech-bio convergence. | modivc.com | Houston, United States | ||
Tech & offline focused VC firm investing in seed & early stage companies in the UK & US | bluewirecapital.com | London, United Kingdom | ||
Venture capital investing with a focus on diversity and inclusion in the ecosystem. | gaingels.com |
Investor details for Ignota Labs
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Ignota Labs
3 people are tracked at Ignota Labs (3 in leadership); the tracked headcount is 6.
| Name | Role | Group |
|---|---|---|
Layla Hosseini-Gerami | Co-Founder | Leadership |
Sam Windsor | Co-Founder & Co-CEO | Leadership |
Jordan Lane | Co-CEO | Leadership |
Complete people profiles for Ignota Labs
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Ignota Labs
2 dated milestones of Ignota Labs across 4 years, from founding to its latest funding, stage changes and deals.
- Founded Ignota Labs is founded.
- Funding First funding round of $6.9M.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Ignota Labs
Complete news archive for Ignota Labs
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ignota Labs
Ignota Labs was founded in 2021 and raised its 1st funding round 4 years after it was founded.
Ignota Labs is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Sam Windsor is the CEO of Ignota Labs, as recorded in our data. They have also founded this company.
Ignota Labs is a funded company, having raised a total of $6.9M across 1 funding round to date. The company's 1st funding round was a Seed of $6.9M, raised on Feb 2025.
Ignota Labs has 6 employees.
Ignota Labs is a technology startup in the pharmaceutical sector that provides AI-driven toxicity prediction tools for early-stage drug discovery scientists. Their suite of tools, TOXSCAPE, helps scientists identify and understand safety issues during the drug discovery process, reducing expensive setbacks and delays.
Ignota Labs offers SAFEPATH.
Ignota Labs has 5 investors. Key investors include Montage Ventures, AIX Ventures, Modi Ventures, Blue Wire Capital, and Gaingels.
Ignota Labs operates through Absoluteai Ltd.